Iron Repletion for Patients with Heart Failure and Kidney Dysfunction.
作者信息
Coyne Daniel W
机构信息
Division of Nephrology , School of Medicine , Washington University, St. Louis , Missouri.
出版信息
Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1111-1112. doi: 10.2215/CJN.0000000000000264. Epub 2023 Aug 9.
Abstract
摘要
相似文献
1
Iron Repletion for Patients with Heart Failure and Kidney Dysfunction.心力衰竭合并肾功能不全患者的铁剂补充
Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1111-1112. doi: 10.2215/CJN.0000000000000264. Epub 2023 Aug 9.
2
Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence.静脉铁剂治疗缺铁合并心力衰竭患者：现代证据回顾。
Curr Opin Cardiol. 2024 May 1;39(3):178-187. doi: 10.1097/HCO.0000000000001121. Epub 2024 Feb 14.
3
Treatment with iron of patients with heart failure with and without anemia.铁剂治疗伴或不伴贫血的心力衰竭患者。
Heart Fail Clin. 2010 Jul;6(3):305-12. doi: 10.1016/j.hfc.2010.02.002.
4
Intravenous Iron Therapy in Heart Failure.心力衰竭的静脉铁治疗。
Heart Fail Clin. 2018 Oct;14(4):537-543. doi: 10.1016/j.hfc.2018.06.003. Epub 2018 Aug 18.
5
Iron repletion in heart failure patients.心力衰竭患者的铁补充
Hypertension. 2011 Mar;57(3):381-2. doi: 10.1161/HYPERTENSIONAHA.110.166868. Epub 2011 Jan 24.
6
Iron repletion in heart failure: a symptomatic win, a survival miss.心力衰竭中的铁补充：症状改善成功，生存获益失败。
Heart Fail Rev. 2025 May 31. doi: 10.1007/s10741-025-10532-z.
7
[Anemia and iron deficiency - treatment options in chronic kidney disease and in chronic heart failure].[贫血与缺铁——慢性肾脏病和慢性心力衰竭的治疗选择]
Dtsch Med Wochenschr. 2020 Dec;145(24):1775-1780. doi: 10.1055/a-1133-7849. Epub 2020 Nov 30.
8
The Intersection of Heart Failure and Iron Deficiency Anemia: Diagnostic and Therapeutic Approaches.心力衰竭与缺铁性贫血的交集：诊断与治疗方法
Curr Cardiol Rev. 2025;21(3):30-43. doi: 10.2174/011573403X331380241111091452.
9
Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.心力衰竭伴贫血的治疗：静脉铁剂治疗心血管疾病的潜在风险和获益。
Cardiol Rev. 2010 Sep-Oct;18(5):240-50. doi: 10.1097/CRD.0b013e3181e71150.
10
Ironing out the wrinkles: Unanswered questions in intravenous iron repletion in heart failure.解决难题：心力衰竭静脉补铁中未解决的问题
Eur J Heart Fail. 2023 Jul;25(7):1091-1093. doi: 10.1002/ejhf.2893. Epub 2023 May 25.
本文引用的文献
1
Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.缺铁伴住院心力衰竭和肾功能降低患者的羧基麦芽糖铁。
Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1124-1134. doi: 10.2215/CJN.0000000000000223. Epub 2023 Jun 29.
2
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.达普司他用于治疗未接受透析患者的贫血
N Engl J Med. 2021 Dec 16;385(25):2313-2324. doi: 10.1056/NEJMoa2113380. Epub 2021 Nov 5.
3
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.铁羧基麦芽糖治疗急性心力衰竭出院后缺铁：一项多中心、双盲、随机、对照试验。
Lancet. 2020 Dec 12;396(10266):1895-1904. doi: 10.1016/S0140-6736(20)32339-4. Epub 2020 Nov 13.
4
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.维持性血液透析患者的静脉铁剂治疗。
N Engl J Med. 2019 Jan 31;380(5):447-458. doi: 10.1056/NEJMoa1810742. Epub 2018 Oct 26.
5
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.缺铁性心力衰竭患者中铁羧基麦芽糖的应用对住院率和死亡率的影响：一项个体患者数据荟萃分析。
Eur J Heart Fail. 2018 Jan;20(1):125-133. doi: 10.1002/ejhf.823. Epub 2017 Apr 24.
6
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.FIND-CKD：一项针对慢性肾脏病合并缺铁性贫血患者比较静脉注射羧麦芽糖铁与口服铁剂的随机试验。
Nephrol Dial Transplant. 2014 Nov;29(11):2075-84. doi: 10.1093/ndt/gfu201. Epub 2014 Jun 2.
7
Darbepoetin alfa in systolic heart failure.
N Engl J Med. 2013 Aug 1;369(5):488-9. doi: 10.1056/NEJMc1306321.
8
The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial.在正常红细胞压积试验中，针对更高的血红蛋白水平并没有改善与健康相关的生活质量。
Kidney Int. 2012 Jul;82(2):235-41. doi: 10.1038/ki.2012.76. Epub 2012 Mar 21.
9
Ferric carboxymaltose in patients with heart failure and iron deficiency.缺铁性心力衰竭患者的羧基麦芽糖铁。
N Engl J Med. 2009 Dec 17;361(25):2436-48. doi: 10.1056/NEJMoa0908355. Epub 2009 Nov 17.
10
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.阿法达贝泊汀治疗2型糖尿病和慢性肾病的一项试验。
N Engl J Med. 2009 Nov 19;361(21):2019-32. doi: 10.1056/NEJMoa0907845. Epub 2009 Oct 30.
Zotero 插件